Peri‐liver transplant hyperglycemia can be attributed to several factors, including post‐reperfusion hepatocyte injury, insulin resistance stemming from underlying liver disease, surgical stress, and the use of immunosuppressive drugs. This evidence concerns the gene INS and Hyperglycemia.